Initial Growth Factor
Venture Studio
THE IGF - VS CELL'S PURPOSE
At IGFVS ( Initial Growth Factor Venture Studio) , we believe the strongest companies are built from the cell up. Named after the body’s primary growth mediator, our venture studio serves as the "first capital" for ambitious founders at the angel and seed stages. We provide more than just funding pairing, we deliver the essential nutrients, mentorship, infrastructure, and network, that can help transform a raw idea into a market dominant organism.
OUR FOCUS
We believe the next decade of healthcare will be defined by a shift from reactive survival to proactive vitality. Our conviction is that the most valuable companies of the 2030s will be those that bridge the gap between clinical intervention and daily wellness.
We scout and manage companies in the "Life Cycle of Care" with supporting technologies that accelerate recovery from trauma, optimize physical performance, and restore dignity to aging.
Whether through a surgical tool or a digital therapeutic, our portfolio contains products that measurably improve how a human being experiences their day-to-day life.
LATEST
PROJECTS
TYBR Health (FDA Approved)
Post Operative Adhesive Scarring Management
Investment Round: SEED (Pre Rev)
ADDX
Private Markets Investments
Investment Round: Angel (Pre Rev)
Current Valuation: USD400M
01
02
OPALITE HEALTH (YC'26)
Real Time Medical Interpretation
Investment Round: SEED
CLARITY
TECHNOLOGIES
brain computer interface uses the power of light and sound to treat neurodegenerative diseases, without the need for drugs or implants.
Investment Round: SEED
03
04
ENSEMBLE VC
Investment Level: LP
05
Capital
Pairing
IGFVS ALPHA sources between 50K to 250K USD into angel and seed rounds. The current focus is on medical, healthcare and wellness startups with some side interest in fintech, defense and mobility tech.